Tobii Dynavox AB Stock

Equities

TDVOX

SE0017105620

Integrated Hardware & Software

Market Closed - Nasdaq Stockholm 11:29:34 2024-04-24 am EDT 5-day change 1st Jan Change
56.7 SEK -7.05% Intraday chart for Tobii Dynavox AB -7.20% +34.68%
Sales 2024 * 1.88B 174M Sales 2025 * 2.11B 194M Capitalization 6.4B 589M
Net income 2024 * 136M 12.52M Net income 2025 * 183M 16.85M EV / Sales 2024 * 3.65 x
Net Debt 2024 * 482M 44.37M Net Debt 2025 * 270M 24.83M EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
48 x
P/E ratio 2025 *
35.5 x
Employees 701
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.23%
1 week-6.44%
Current month+0.69%
1 month+2.65%
3 months+39.66%
6 months+109.75%
Current year+38.00%
More quotes
1 week
51.00
Extreme 51
63.30
1 month
51.00
Extreme 51
63.30
Current year
39.50
Extreme 39.5
63.30
1 year
22.50
Extreme 22.5
63.30
3 years
17.46
Extreme 17.458
63.30
5 years
17.46
Extreme 17.458
63.30
10 years
17.46
Extreme 17.458
63.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 13-12-31
Director of Finance/CFO 48 17-12-31
Chief Operating Officer 64 13-12-31
Members of the board TitleAgeSince
Chairman 62 14-12-31
Founder 50 00-12-31
Director/Board Member 58 -
More insiders
Date Price Change Volume
24-04-24 56.7 -7.05% 1 119 020
24-04-23 61 +0.16% 1,118,769
24-04-22 60.9 +2.35% 585,944
24-04-19 59.5 -0.83% 484,054
24-04-18 60 -3.38% 528,973

Delayed Quote Nasdaq Stockholm, April 24, 2024 at 05:05 am EDT

More quotes
Tobii Dynavox AB is a Sweden-based company engaged in development and sales of assistive technology for communication. The Company's products enable its users to improve the quality of thier lives and exist more independently. The technology offers a range of of solutions, including specially designed communication devices, controlled by eye movements or touchscreens, as well as variety of software applications for communication and special education. Tobii Dynavox offers solution that, in addition to software and communication devices, also consists of assisting prescribers with user testing, helping users obtain reimbursement, and providing assistance so users can get started and learn how to use the solutions. The Company operates worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
61 SEK
Average target price
53.5 SEK
Spread / Average Target
-12.30%
Consensus